Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

The academic center effect: Better outcomes for patients with DLBCL

View Full Paper
Ask AI
Bookmark
Share

Authors

LRLaura Reyes-UribeLBLeyla BojaniniADAdolfo Diaz Duque

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows improved outcomes for DLBCL patients at academic centers versus community programs, indicating enhanced oncology care.

Key Points

  • Patients treated at academic centers demonstrated significantly better outcomes compared to those at community programs.
  • After adjusting for demographics and clinical variables, median overall survival was 6.4 years for academic centers versus 5.8 years for community programs.
  • Analysis of 311,188 patients diagnosed with DLBCL from 2004 to 2022 showed systemic therapy was received by 69% in academic centers compared to 63% in community programs.
  • These findings highlight the necessity for enhanced partnerships between community and academic centers to improve cancer care.

Cite This Study

Reyes-Uribe et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d543https://doi.org/10.1182/blood-2025-6314
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patients with burkitt's lymphoma have a better survival probability if treated in an academic cancer program2025
  2. 2Academic cancer programs deliver improved long-term survival in nodular lymphocyte predominant Hodgkin lymphoma: Insights from 7,000+ United States patients2025
  3. 3A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients2025
  4. 4Outcomes of primary cutaneous anaplastic large cell lymphoma across u.S. cancer care settings: A national cancer database analysis.2025
  5. 5Real-world outcomes in T-cell/histiocyte-rich large B-cell lymphoma: Insights from the largest u.S. cohort to date2025